Advertisement

Lasers in Medical Science

, Volume 34, Issue 9, pp 1873–1880 | Cite as

Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis

  • Rania Ahmed El-Tatawy
  • Heba Ahmed Aliweh
  • Doaa Salah HegabEmail author
  • Raghda Ahmed Zaki Talaat
  • Maii Atef Shams Eldeen
Original Article
  • 145 Downloads

Abstract

Onychomycosis is a common chronic-resistant nail disease. Traditional treatment has its limitations and side effects. This study aimed to evaluate the role of fractional CO2 laser and topical tioconazole 28% nail lacquer in the treatment of fingernail onychomycosis, as sole treatment modalities and in combination. Thirty patients with culture-proven onychomycosis were included and randomly divided into three equal groups. Laser group received six fractional carbon dioxide (CO2) laser sessions at monthly intervals; topical group received topical tioconazole 28% nail lacquer twice daily for 6 months, and combined group received six fractional CO2 laser sessions at monthly intervals with topical tioconazole twice daily for 6 months. Treatment outcome was evaluated through physician’s evaluation of improvement using onychomycosis severity index score (OSI), patients’ satisfaction, side effect evaluation, and mycological culture (assessed after the end of treatment). At the end of treatment, both laser and combined groups showed significantly better degrees of improvement (P = 0.036, 0.024, respectively) and patient’s satisfaction (P = 0.046, 0.003, respectively) in comparison with topical group. Mycological clearance in fungal cultures was significantly higher in combined group than topical group after the end of treatment (P = 0.007). Fractional CO2 laser is a safe and effective treatment modality for onychomycosis. Its efficacy approximates that of fractional CO2 laser combined with topical tioconazole 28% nail lacquer and surpasses that of topical tioconazole 28% monotherapy. It is expected to be an excellent choice for patients in whom systemic antifungals are contraindicated or who are unresponsive or intolerant to topical antifungals.

Keywords

Fractional Co2 laser Onychomycosis Tioconazole Topical 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Kim DM, Suh MK, Ha GY, Sohng SH (2012) Fingernail onychomycosis due to Aspergillus Niger. Ann Dermatol 24:459–463CrossRefGoogle Scholar
  2. 2.
    Elewski BE, Tosti A (2015) Risk factors and comorbidities for onychomycosis: implications for treatment with topical therapy. J Clin Aesthet Dermatol 8(11):38–42PubMedPubMedCentralGoogle Scholar
  3. 3.
    Hay RJ, Baran R (2011) Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol 65(6):1219–1227CrossRefGoogle Scholar
  4. 4.
    Rosen T, Stein Gold LF (2016) Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action. Semin Cutan Med Surg 35(3):S51–S55CrossRefGoogle Scholar
  5. 5.
    Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Takwale A, Shemer A, Babaev M, Grover C, Di Chiacchio NG, Taborda PRO, Taborda VBA, Shear NH, Piguet V, Tosti A (2018) Global perspectives for the management of onychomycosis. Int J Dermatol.  https://doi.org/10.1111/ijd.14346 CrossRefGoogle Scholar
  6. 6.
    Zhang RN, Wang DK, Zhuo FL, Duan XH, Zhang XY, Zhao JY (2012) Long-pulse Nd:YAG 1064-nm laser treatment for onychomycosis. Chin Med J 125:3288–3291PubMedGoogle Scholar
  7. 7.
    Gupta AK, Simpson FC, Heller DF (2016) The future of lasers in onychomycosis. J Dermatolog Treat 27:167–172CrossRefGoogle Scholar
  8. 8.
    Helou J, Maatouk I, Hajjar MA, Moutran R (2016) Evaluation of Nd:YAG laser device efficacy on onychomycosis: a case series of 30 patients. Mycoses 59:7–11CrossRefGoogle Scholar
  9. 9.
    Lim EH, Kim HR, Park YO, Lee Y, Seo YJ, Kim CD et al (2014) Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream. J Am Acad Dermatol 70(5):918–923CrossRefGoogle Scholar
  10. 10.
    Kozarev J, Vizintin Z (2010) Novel laser therapy in treatment of onychomycosis. J Laser Health Acad 1:1–9Google Scholar
  11. 11.
    Watanabe D, Kawamura C, Masuda Y, Akita Y, Tamada Y, Matsumoto Y (2008) Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol 144(1):19–21CrossRefGoogle Scholar
  12. 12.
    Dai T, Tegos GP, Rolz-Cruz G, Cumbie WE, Hamblin MR (2008) Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol 158(6):1239–1246CrossRefGoogle Scholar
  13. 13.
    Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J et al (2011) A new classification system for grading the severity of onychomycosis: onychomycosis severity index. Arch Dermatol 147(11):1277–1282CrossRefGoogle Scholar
  14. 14.
    Shi J, Li J, Huang H, Permatasari F, Liu J, Xu Y et al (2017) The efficacy of fractional carbon dioxide (CO2) laser combined with terbinafine hydrochloride 1% cream for the treatment of onychomycosis. J Cosmet Laser Ther 19(6):353–359CrossRefGoogle Scholar
  15. 15.
    Hay RJ, Mackie RM, Clayton YM (1985) Tioconazole nail solution—an open study of its efficacy in onychomycosis. Clin Exper Dermatol 10(2):111–115CrossRefGoogle Scholar
  16. 16.
    Baran R, Kaoukhov A (2005) Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol 19(1):21–29CrossRefGoogle Scholar
  17. 17.
    Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V et al (2009) An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 23(7):773–781CrossRefGoogle Scholar
  18. 18.
    Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H et al (2013) Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol 68(4):600–608CrossRefGoogle Scholar
  19. 19.
    Bhatta AK, Keyal U, Huang X, Zhao JJ (2016) Fractional carbon-dioxide (CO2) laser-assisted topical therapy for the treatment of onychomycosis. J Am Acad Dermatol 74:916–923CrossRefGoogle Scholar
  20. 20.
    Zhou BR, Lu Y, Permatasari F, Huang H, Li J, Liu J et al (2016) The efficacy of fractional carbon dioxide (CO2) laser combined with luliconazole 1% cream for the treatment of onychomycosis: a randomized, controlled trial. Medicine 95(44):e5141CrossRefGoogle Scholar
  21. 21.
    Abd El-Aal EB, Abdo HM, Ibrahim SM, Eldestawy MT (2018) Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. J Dermatolog Treat 28:1–6Google Scholar
  22. 22.
    Yang Y, Liu H, Yang R, Huang X, Jing D, Wang L (2015) Efficacy of a superpulse-mode fractional carbon dioxide laser for the treatment of onychomycosis: a clinical observational study. Chinese J Dermatol 48(8):526–530Google Scholar
  23. 23.
    Hira K, Yamada H, Takahashi Y, Ogawa H (2002) Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol 16:273–275CrossRefGoogle Scholar
  24. 24.
    Alam M, Pantanowitz L, Harton AM, Arndt KA, Dover JS (2003) A prospective trial of fungal colonization after laser resurfacing of the face: correlation between culture positivity and symptoms of pruritus. Dermatol Surg 29:255–260PubMedGoogle Scholar
  25. 25.
    Borovoy M, Tracy M (1992) Noninvasive CO 2 laser fenestration improves treatment of onychomycosis. Clin Laser Mon 10:123–124PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  • Rania Ahmed El-Tatawy
    • 1
  • Heba Ahmed Aliweh
    • 1
  • Doaa Salah Hegab
    • 1
    • 2
    Email author
  • Raghda Ahmed Zaki Talaat
    • 3
  • Maii Atef Shams Eldeen
    • 3
  1. 1.Dermatology and Venereology Department, Faculty of MedicineTanta UniversityTantaEgypt
  2. 2.Faculty of Medicine, Dermatology and Venereology DepartmentTanta University HospitalsTantaEgypt
  3. 3.Medical Microbiology and Immunology Department, Faculty of MedicineTanta UniversityTantaEgypt

Personalised recommendations